| abstract |
The invention discloses a newly discovered compound and medicinal use thereof, which are characterized by transforming the structure of salvianolic acid F in salvia miltiorrhiza to screen out a new compound with high stability, high membrane permeability and high bioavailability through stability tests, Lop determination, pharmacodynamics tests and the like. The compound has better pharmacological effect in the treatment of cardiovascular and cerebrovascular diseases and the like. |